The Predictive Value of Cystatin C in Monitoring of B Non-Hodgkin Lymphomas: Relation to Biochemical and Clinical Parameters

Table 2

Correlation of cystatin C with IL-6, 𝛽₂M, and CRP.

Parameter	Group	Time at diagnosis			Before IV chemotherapy
		Number of patients	Correlation coefficient	P value	Number of patients	Correlation coefficient	P value
IL-6	All patients^a	31	0,056	0,766	26	−0,268	0,186
	Aggressive	26	0,079	0,701	20	−0,138	0,561
	Extranodal	13	0,082	0,789	11	0,345	0,298
	Nodal	13	0,110	0,721	9	−0,500	0,170
𝛽2M	All patients^a	50	0,332^∗	0,019	36	0,460^∗∗	0,005
	Aggressive	39	0,286	0,077	31	0,488^∗∗	0,005
	Extranodal	22	0,201	0,370	18	0,418	0,084
	Nodal	17	0,522^∗	0,032	13	0,626^∗∗	0,022
CRP	All patients^a	52	0,107	0,451
	Aggressive	41	0,181	0,258
	Extranodal	23	0,381	0,073
	Nodal	18	−0,028	0,913

∗Statistically significant correlation.
^aTotal group of patients.
**Statistically highly significant correlation.